Novo Nordisk (NVO +2.97%) is losing market share in the lucrative weight loss treatment category.
*Stock prices used were the afternoon prices of Nov. 17, 2025. The video was published on Nov. 19, 2025.

The management team conducted a cost-cutting effort that is likely to result in a more efficient business.
Novo Nordisk (NVO +2.97%) is losing market share in the lucrative weight loss treatment category.
*Stock prices used were the afternoon prices of Nov. 17, 2025. The video was published on Nov. 19, 2025.


*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.